Vivanza Biosciences MD, chairman, board of directors and AGM
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹1.60.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6.40 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 14.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 Jul 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Jul 2026
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,075
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/S. Shivam Soni & CoPeer-review certificate valid to Aug 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Vivanza Biosciences AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Vivanza Biosciences share news and announcements
Annual general meeting, 11 Sep 2026
19,498 shareholders on the register on 4 Sep 2026; present: 1 promoter and 39 others; votes counted by Chintan K. Patel / Chintan K. Patel, Practicing Company Secretary.The company's voting result (opens in a new tab)
Adoption of Audited Standalone and Consolidated Fi nancial Statements of the Company for the Financial Year ended 31st March 2026 tc~gether with the reports of Board of Directors and Independent Auditor's reports thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- Appointment of Mr. Jayendra Mehta (DIN: 08210602) Director who liable to retires by rotation and being eligible, offers himself ~or reappointment.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.60%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- To approve regularization of Additional Director Mr. H. A. Parikh (DIN: 00027820) as Non-Executive, Non Independent Director of the Company.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- To approve the material related party transaction(s) proposed to be entered into by the Company during the financial year 2026-2027SpecialPromoters have an interest in it99.52% for0.48% against
Against: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 100.00% · promoters 0.00% · institutions 0.00% · other public 100.00%
- To consider the adoption of a new set of Memorandum of Association in line with Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- To consider the adoption of new set of Articles of Association in line with Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- To approve increase in borrowing limits under section 180(1){c) of the Companies Act, 2013SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.60%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- To approve investments, give loans, guarantees/letter of comfort/letter of support and security under section 186 of the ActSpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.60%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
- To approve advancement of any loan I financial assistance /give guarantee/provide security/ letter of comfort/letter of support under section 185 of the Act in which directors are interestedSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 100.00% · promoters 100.00% · institutions 0.00% · other public 100.00%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.